+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Periodontal Inflammation - Pipeline Insight, 2025 - Product Thumbnail Image

Periodontal Inflammation - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Restrictive Cardiomyopathy (RCM) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Restrictive Cardiomyopathy (RCM) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 61 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more